Synopsis
Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Acamprosate
2. Acamprostate
3. Acetyl Homotaurinate, Calcium
4. Acetylhomotaurinate, Calcium
5. Acetylhomotaurine, Calcium
6. Acetylhomotaurine, Sodium
7. Aotal
8. Calcium Acetyl Homotaurinate
9. Calcium Acetylhomotaurinate
10. Calcium Acetylhomotaurine
11. Campral
12. Campral Ec
13. N Acetylhomotaurine
14. N Acetylhomotaurine, Monolithium Salt
15. N Acetylhomotaurine, Monopotassium Salt
16. N Acetylhomotaurine, Monosodium Salt
17. N-acetylhomotaurine
18. N-acetylhomotaurine, Calcium (2:1) Salt
19. N-acetylhomotaurine, Magnesium (2:1) Salt
20. N-acetylhomotaurine, Monolithium Salt
21. N-acetylhomotaurine, Monopotassium Salt
22. N-acetylhomotaurine, Monosodium Salt
23. N-acetylhomotaurine, Zinc (2:1) Salt
24. Regtect
25. Sodium Acetylhomotaurine
26. Zulex
1. 77337-73-6
2. Campral
3. Campral Ec
4. Alcomed
5. Sobriol
6. Aotal
7. Calcium 3-acetamidopropane-1-sulfonate
8. Calcium Acetylhomotaurinate
9. Acamprosate Calcium [usan]
10. Calcium N-acetylhomotaurinate
11. Calcium 3-(acetylamino)propane-1-sulfonate
12. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
13. Acamprosate (calcium)
14. Nsc-759186
15. Chebi:51042
16. Sn-102
17. 59375n1d0u
18. Calcium Bis(3-acetamidopropane-1-sulfonate)
19. Dsstox_cid_27529
20. Dsstox_rid_82399
21. Dsstox_gsid_47529
22. 77337-73-6 (calcium Salt); 77337-76-9 (free Acid).
23. Calcium Acamprosate
24. Cas-77337-73-6
25. Calcium(2+) 3-(acetylamino)propanesulphonate
26. Ncgc00167462-01
27. Einecs 278-665-3
28. N-acetylhomotaurine Calcium
29. Unii-59375n1d0u
30. Campral (tn)
31. Regtect (tn)
32. Calcium;3-acetamidopropane-1-sulfonate
33. Calcium 3-(acetylamino)propanesulphonate
34. Acamprosate Calcium- Bio-x
35. Schembl137771
36. 3-(acetylamino)-1-propanesulfonic Acid Calcium Salt
37. Acamprosate Calcium [mi]
38. Chembl2068724
39. Dtxsid6047529
40. Acamprosate Calcium (jan/usan)
41. Acamprosate Calcium [jan]
42. Hms3264j11
43. Hms3713l22
44. Pharmakon1600-01505711
45. Acamprosate Calcium [mart.]
46. Tox21_112466
47. Tox21_302606
48. Acamprosate Calcium [usp-rs]
49. Acamprosate Calcium [who-dd]
50. Mfcd00886588
51. Nsc759186
52. Akos015895192
53. Ab07649
54. Ac-5599
55. Calcium 3-acetamido-1-propanesulfonate
56. Ccg-213526
57. Ks-5292
58. Nsc 759186
59. Acamprosate Calcium [orange Book]
60. Ncgc00256899-01
61. Acamprosate Calcium [ep Monograph]
62. Ba164134
63. Acamprosate Calcium [usp Monograph]
64. Db-056209
65. Ft-0621712
66. 3-acetamido-1-propanesulfonate Calcium
67. 3-acetamido-1-propanesulphonate Calcium
68. D02780
69. T71327
70. 3-acetamido-1-propanesulfonic Acid Calcium Salt
71. A839056
72. Calcium 3-(acetylamino)propane-1-sulphonate
73. Q27122289
74. 3-(acetylamino)-1-propanesulfonic Acid Hemicalcium Salt
75. Z1696861853
76. 5-methoxy-2-methyl-1-propyl-1h-indole-3-carboxylicacid
77. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
Molecular Weight | 400.5 g/mol |
---|---|
Molecular Formula | C10H20CaN2O8S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 400.0286988 g/mol |
Monoisotopic Mass | 400.0286988 g/mol |
Topological Polar Surface Area | 189 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 202 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Acamprosate calcium |
Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
Active Ingredient | Acamprosate calcium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 333mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
2 of 2 | |
---|---|
Drug Name | Acamprosate calcium |
Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
Active Ingredient | Acamprosate calcium |
Dosage Form | Tablet, delayed release |
Route | Oral |
Strength | 333mg |
Market Status | Prescription |
Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
Alcohol Deterrents
Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Acamprosate Calcium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acamprosate Calcium, including repackagers and relabelers. The FDA regulates Acamprosate Calcium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acamprosate Calcium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acamprosate Calcium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acamprosate Calcium supplier is an individual or a company that provides Acamprosate Calcium active pharmaceutical ingredient (API) or Acamprosate Calcium finished formulations upon request. The Acamprosate Calcium suppliers may include Acamprosate Calcium API manufacturers, exporters, distributors and traders.
click here to find a list of Acamprosate Calcium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Acamprosate Calcium DMF (Drug Master File) is a document detailing the whole manufacturing process of Acamprosate Calcium active pharmaceutical ingredient (API) in detail. Different forms of Acamprosate Calcium DMFs exist exist since differing nations have different regulations, such as Acamprosate Calcium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Acamprosate Calcium DMF submitted to regulatory agencies in the US is known as a USDMF. Acamprosate Calcium USDMF includes data on Acamprosate Calcium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Acamprosate Calcium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Acamprosate Calcium suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Acamprosate Calcium Drug Master File in Korea (Acamprosate Calcium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Acamprosate Calcium. The MFDS reviews the Acamprosate Calcium KDMF as part of the drug registration process and uses the information provided in the Acamprosate Calcium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Acamprosate Calcium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Acamprosate Calcium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Acamprosate Calcium suppliers with KDMF on PharmaCompass.
A Acamprosate Calcium CEP of the European Pharmacopoeia monograph is often referred to as a Acamprosate Calcium Certificate of Suitability (COS). The purpose of a Acamprosate Calcium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Acamprosate Calcium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Acamprosate Calcium to their clients by showing that a Acamprosate Calcium CEP has been issued for it. The manufacturer submits a Acamprosate Calcium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Acamprosate Calcium CEP holder for the record. Additionally, the data presented in the Acamprosate Calcium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Acamprosate Calcium DMF.
A Acamprosate Calcium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Acamprosate Calcium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Acamprosate Calcium suppliers with CEP (COS) on PharmaCompass.
A Acamprosate Calcium written confirmation (Acamprosate Calcium WC) is an official document issued by a regulatory agency to a Acamprosate Calcium manufacturer, verifying that the manufacturing facility of a Acamprosate Calcium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acamprosate Calcium APIs or Acamprosate Calcium finished pharmaceutical products to another nation, regulatory agencies frequently require a Acamprosate Calcium WC (written confirmation) as part of the regulatory process.
click here to find a list of Acamprosate Calcium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acamprosate Calcium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acamprosate Calcium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acamprosate Calcium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acamprosate Calcium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acamprosate Calcium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acamprosate Calcium suppliers with NDC on PharmaCompass.
Acamprosate Calcium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acamprosate Calcium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acamprosate Calcium GMP manufacturer or Acamprosate Calcium GMP API supplier for your needs.
A Acamprosate Calcium CoA (Certificate of Analysis) is a formal document that attests to Acamprosate Calcium's compliance with Acamprosate Calcium specifications and serves as a tool for batch-level quality control.
Acamprosate Calcium CoA mostly includes findings from lab analyses of a specific batch. For each Acamprosate Calcium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acamprosate Calcium may be tested according to a variety of international standards, such as European Pharmacopoeia (Acamprosate Calcium EP), Acamprosate Calcium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acamprosate Calcium USP).
LOOKING FOR A SUPPLIER?